Direct Biologics
Phase 2Direct Biologics has developed the next generation of naturally bioactive products for regenerative therapies. Our novel technologies are used for developing Extracellular Vesicle (EV) products derived from adult human mesenchymal stem/stromal cells, which contain bioactive molecules with clinical therapeutic potential.
Founded
2017
Focus
Biologics
About
Direct Biologics has developed the next generation of naturally bioactive products for regenerative therapies. Our novel technologies are used for developing Extracellular Vesicle (EV) products derived from adult human mesenchymal stem/stromal cells, which contain bioactive molecules with clinical therapeutic potential.
Funding History
2Total raised: $35M
Series B$25MUndisclosedJun 15, 2021
Series A$10MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2017
LocationAustin, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile